Skip to main content

How does Rhopressa work?

Medically reviewed by Last updated on Jan 2, 2024.

Official answer


Rhopressa reduces intraocular pressure (IOP) by increasing outflow of aqueous humor (the fluid inside the eye) through the trabecular meshwork, the main fluid drain of the eye.

Rhopressa (netarsudil ophthalmic solution) 0.02%, from Aerie Pharmaceuticals, is a Rho Kinase Inhibitor. Rhopressa, a once daily eye drop for lowering IOP in patients with open-angle glaucoma or ocular hypertension, was FDA-approved in December 2017.

Related medical questions

Drug information

Related support groups